Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Human hepatoma cell line HepaRG in bioartificial liver

EU orphan designation number: EU/3/16/1818   
Active ingredient: Human hepatoma cell line HepaRG in bioartificial liver
Indication: Treatment of acute liver failure
Sponsor: Hep-Art Medical Devices BV
Meibergdreef 45, 1105 BA Amsterdam, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/01/2017 Orphan designation EMA/OD/222/16 (2017)222 of 12/01/2017